###begin article-title 0
###xml 44 49 <span type="species:ncbi:9606">Human</span>
Dissection of the Transformation of Primary Human Hematopoietic Cells by the Oncogene NUP98-HOXA9
###end article-title 0
###begin p 1
Conceived and designed the experiments: NRY. Performed the experiments: ERY NS. Analyzed the data: ERY AT NRY. Contributed reagents/materials/analysis tools: AMAN JD YH AT. Wrote the paper: NRY. Prepared figures: ERY.
###end p 1
###begin p 2
###xml 1185 1190 1185 1190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAP1A</italic>
###xml 1192 1196 1192 1196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HEY1</italic>
###xml 1202 1207 1202 1207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTGS2</italic>
###xml 1209 1214 1209 1214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COX-2</italic>
###xml 519 524 <span type="species:ncbi:9606">human</span>
###xml 630 635 <span type="species:ncbi:10090">mouse</span>
###xml 723 728 <span type="species:ncbi:9606">human</span>
###xml 819 824 <span type="species:ncbi:9606">human</span>
###xml 1037 1042 <span type="species:ncbi:9606">human</span>
NUP98-HOXA9 is the prototype of a group of oncoproteins associated with acute myeloid leukemia. It consists of an N-terminal portion of NUP98 fused to the homeodomain of HOXA9 and is believed to act as an aberrant transcription factor that binds DNA through the homeodomain. Here we show that NUP98-HOXA9 can regulate transcription without binding to DNA. In order to determine the relative contributions of the NUP98 and HOXA9 portions to the transforming ability of NUP98-HOXA9, the effects of NUP98-HOXA9 on primary human CD34+ cells were dissected and compared to those of wild-type HOXA9. In contrast to previous findings in mouse cells, HOXA9 had only mild effects on the differentiation and proliferation of primary human hematopoietic cells. The ability of NUP98-HOXA9 to disrupt the differentiation of primary human CD34+ cells was found to depend primarily on the NUP98 portion, whereas induction of long-term proliferation required both the NUP98 moiety and an intact homeodomain. Using oligonucleotide microarrays in primary human CD34+ cells, a group of genes was identified whose dysregulation by NUP98-HOXA9 is attributable primarily to the NUP98 portion. These include RAP1A, HEY1, and PTGS2 (COX-2). Their functions may reflect the contribution of the NUP98 moiety of NUP98-HOXA9 to leukemic transformation. Taken together, these results suggest that the effects of NUP98-HOXA9 on gene transcription and cell transformation are mediated by at least two distinct mechanisms: one that involves promoter binding through the homeodomain with direct transcriptional activation, and another that depends predominantly on the NUP98 moiety and does not involve direct DNA binding.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 209 212 209 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Borrow1">[1]</xref>
###xml 214 217 214 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Nakamura1">[2]</xref>
###xml 356 359 356 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Argiropoulos1">[3]</xref>
###xml 417 420 417 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Kasper1">[4]</xref>
###xml 422 425 422 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Nakamura2">[5]</xref>
###xml 427 430 427 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Ghannam1">[6]</xref>
###xml 432 435 432 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Bei1">[7]</xref>
###xml 437 440 437 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Bai1">[8]</xref>
###xml 442 445 442 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Wang1">[9]</xref>
###xml 447 451 447 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Hirose1">[10]</xref>
###xml 567 570 567 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Wang1">[9]</xref>
###xml 572 576 572 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Hirose1">[10]</xref>
###xml 578 582 578 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Pineault1">[11]</xref>
###xml 584 588 584 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Kroon1">[12]</xref>
###xml 590 594 590 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Calvo1">[13]</xref>
###xml 596 600 596 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Gurevich1">[14]</xref>
###xml 657 660 657 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Kasper1">[4]</xref>
###xml 662 665 662 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Ghannam1">[6]</xref>
###xml 667 671 667 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Pineault1">[11]</xref>
###xml 673 677 673 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Kroon1">[12]</xref>
###xml 679 683 679 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Calvo1">[13]</xref>
###xml 794 798 794 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Takeda1">[15]</xref>
###xml 800 804 800 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Chung1">[16]</xref>
###xml 941 945 941 945 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Kroon1">[12]</xref>
###xml 1030 1038 1030 1038 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1116 1120 1116 1120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Calvo2">[17]</xref>
###xml 508 513 <span type="species:ncbi:10090">mouse</span>
###xml 562 566 <span type="species:ncbi:10090">mice</span>
###xml 688 693 <span type="species:ncbi:9606">human</span>
###xml 936 940 <span type="species:ncbi:10090">mice</span>
###xml 1004 1009 <span type="species:ncbi:10090">mouse</span>
###xml 1204 1209 <span type="species:ncbi:9606">human</span>
NUP98-HOXA9 is an oncogenic fusion protein associated with acute myeloid leukemia (AML) that consists of an N-terminal, FG repeat-rich portion of the nucleoporin NUP98 fused to the homeodomain region of HOXA9 [1], [2]. It is the prototype of several similar leukemogenic fusions linking NUP98 to one of several homeodomain-containing transcription factors [3]. NUP98-HOX fusions act as aberrant transcription factors [4], [5], [6], [7], [8], [9], [10]. They induce proliferation and block differentiation in mouse hematopoietic precursors, and cause leukemia in mice [9], [10], [11], [12], [13], [14]. Some of these effects require a functional homeodomain [4], [6], [11], [12], [13]. In human primary hematopoietic cells, NUP98-HOXA9 induces long-term proliferation and blocks differentiation [15], [16]. It is not known whether these effects are dependent on homeodomain-DNA binding. Wild-type HOXA9 overexpression is leukemogenic in mice [12]. It induces proliferation with a differentiation block in mouse hematopoietic cells in vitro, and these effects are dependent on the presence of a functional homeodomain [17]. However, the effects of HOXA9 on the proliferation and differentiation of primary human hematopoietic cells have not been reported.
###end p 4
###begin p 5
###xml 317 321 317 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Kroon1">[12]</xref>
###xml 331 339 331 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 476 480 476 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Calvo1">[13]</xref>
###xml 591 594 591 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Ghannam1">[6]</xref>
###xml 731 735 731 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Romana1">[18]</xref>
###xml 134 138 <span type="species:ncbi:10090">mice</span>
###xml 407 412 <span type="species:ncbi:10090">mouse</span>
Several lines of evidence suggest that NUP98-HOXA9 may have effects over and above those mediated by the homeodomain. For example, in mice, the leukemia induced by NUP98-HOXA9 is preceded by a myeloproliferative phase whereas leukemia caused by overexpression of wild-type HOXA9 is not preceded by myeloproliferation [12]; and the in vitro effects of NUP98-HOXA9 on the differentiation and proliferation of mouse hematopoietic precursors are more profound than those of HOXA9 [13]. In addition, NUP98-HOXA9 modulates the expression of a larger set of genes than HOXA9 in a myeloid cell line [6]. Finally, while all leukemogenic NUP98 fusions contain an almost identical N-terminal portion of NUP98, most of them lack a homeodomain [18], suggesting that homeodomain-independent mechanisms may contribute to leukemogenesis by NUP98 chimeras.
###end p 5
###begin p 6
###xml 368 372 368 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Palmqvist1">[19]</xref>
###xml 201 206 <span type="species:ncbi:10090">mouse</span>
###xml 1090 1095 <span type="species:ncbi:9606">human</span>
###xml 1320 1325 <span type="species:ncbi:9606">human</span>
###xml 1552 1557 <span type="species:ncbi:9606">human</span>
In a recent study, a mutation that abolishes DNA binding (N51S) was introduced into the homeodomain of another leukemogenic NUP98 fusion, NUP98-HOXD13, and its effect on the gene expression profile in mouse hematopoietic cells was examined. It was found that the homeodomain mutant was still capable of dysregulating a subset of the genes dysregulated by NUP98-HOXD13 [19] indicating that some of the aberrant gene expression is independent of DNA binding by the homeodomain. However, it is not clear whether this homeodomain-independent dysregulation occurs at the transcriptional level and whether it has any functional significance in terms of leukemic transformation. These are among the questions we sought to answer in the current study. We first introduced the N51S mutation into NUP98-HOXA9 and showed that the mutant was capable of regulating transcription in a myeloid cell line without significant binding to DNA. We then compared this mutant to another mutant lacking the NUP98 portion as well as to intact NUP98-HOXA9 and wild-type HOXA9 for their ability to transform primary human CD34+ hematopoietic precursors. The results show that most of the effects of NUP98-HOXA9 on differentiation are dependent on the NUP98 portion and are not abolished by the N51S mutation. Gene expression profiling in primary human CD34+ cells identified a subset of the NUP98-HOXA9 target genes whose dysregulation requires the NUP98 moiety and appears to be independent of the homeodomain. The possible role of these genes in the transformation of primary human hematopoietic cells by NUP98-HOXA9 is discussed.
###end p 6
###begin title 7
Results
###end title 7
###begin title 8
Two distinct modes of transcriptional regulation by NUP98-HOXA9
###end title 8
###begin p 9
###xml 282 285 282 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Ghannam1">[6]</xref>
###xml 287 291 287 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Jankovic1">[20]</xref>
###xml 422 425 422 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Ghannam1">[6]</xref>
###xml 427 431 427 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Takeda1">[15]</xref>
###xml 650 658 650 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006719.s001">Table S1</xref>
###xml 898 905 898 905 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KBTBD10</italic>
###xml 910 913 910 913 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLN</italic>
###xml 960 966 960 966 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006719-g001">Fig. 1</xref>
###xml 159 164 <span type="species:ncbi:9606">human</span>
###xml 404 409 <span type="species:ncbi:9606">human</span>
To determine the role of homeodomain-DNA binding in the regulation of transcription by NUP98-HOXA9, luciferase reporter assays were carried out using the K562 human myeloid cell line. This cell line has been used successfully for analyzing transcriptional regulation by NUP98-HOXA9 [6], [20]. As the genes that NUP98-HOXA9 regulates in K562 cells are largely different from those it regulates in primary human CD34+ cells [6], [15], it was necessary to identify likely transcriptional targets of NUP98-HOXA9 in K562 cells. A microarray study was first undertaken to identify genes whose expression is modulated by NUP98-HOXA9 at an early time point (Table S1). The promoters of several of these genes were subcloned into the pGL4.11 vector upstream of luciferase. The luciferase reporter constructs were introduced into K562 cells along with a construct expressing NUP98-HOXA9. Two of these genes, KBTBD10 and PLN, showed clear transactivation by NUP98-HOXA9 (Fig. 1).
###end p 9
###begin title 10
NUP98-HOXA9 regulates gene expression at the transcriptional level.
###end title 10
###begin p 11
###xml 173 180 173 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KBTBD10</italic>
###xml 231 234 231 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLN</italic>
###xml 251 256 251 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HOXB6</italic>
###xml 271 279 271 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SERPINE1</italic>
###xml 317 320 317 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">JUN</italic>
###xml 404 407 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
K562 cells were transfected by electroporation with either empty pGL4.11 luciferase vector or with vector containing the promoter region of one of the five indicated genes (KBTBD10, kelch repeat and BTB (POZ) domain containing 10; PLN, phospholamban; HOXB6, homeobox B6; SERPINE1, serine proteinase inhibitor E1; and JUN, v-jun sarcoma virus 17 oncogene homolog) in combination with either empty pTracer/CMV-Bsd vector (Control) or vector expressing NUP98-HOXA9. Firefly luciferase activity was measured 48 h after transfection and normalized to a Renilla luciferase internal control. The numbers represent fold change over control (average of 3 independent experiments); error bars represent standard deviation.
###end p 11
###begin p 12
###xml 153 160 153 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006719-g002">Fig. 2A</xref>
###xml 307 311 307 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Gehring1">[21]</xref>
###xml 313 317 313 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Gehring2">[22]</xref>
###xml 441 445 441 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Hirose1">[10]</xref>
###xml 447 451 447 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Calvo2">[17]</xref>
###xml 453 457 453 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Palmqvist1">[19]</xref>
###xml 459 463 459 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Shanmugam1">[23]</xref>
###xml 571 578 571 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006719-g002">Fig. 2B</xref>
###xml 651 658 651 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KBTBD10</italic>
###xml 663 666 663 666 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLN</italic>
###xml 721 728 721 728 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KBTBD10</italic>
###xml 739 746 739 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006719-g003">Fig. 3A</xref>
###xml 800 803 800 803 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLN</italic>
###xml 848 855 848 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006719-g003">Fig. 3B</xref>
###xml 908 911 908 911 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLN</italic>
###xml 1089 1096 1089 1096 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KBTBD10</italic>
###xml 1101 1104 1101 1104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLN</italic>
###xml 1202 1213 1202 1213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006719-g004">Fig. 4A, 4B</xref>
###xml 1219 1221 1219 1221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006719-g005">5A</xref>
###xml 1273 1280 1273 1280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006719-g005">Fig. 5A</xref>
###xml 1481 1488 1481 1488 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KBTBD10</italic>
###xml 1493 1496 1493 1496 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLN</italic>
###xml 1570 1577 1570 1577 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KBTBD10</italic>
###xml 1646 1653 1646 1653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006719-g005">Fig. 5B</xref>
###xml 1746 1749 1746 1749 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLN</italic>
###xml 1798 1805 1798 1805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006719-g005">Fig. 5B</xref>
###xml 1941 1948 1941 1948 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KBTBD10</italic>
###xml 2232 2235 2232 2235 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLN</italic>
###xml 2358 2372 2358 2372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006719-g003">Fig. 3A and 3B</xref>
###xml 2407 2414 2407 2414 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KBTBD10</italic>
###xml 2483 2486 2483 2486 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLN</italic>
To determine whether this transactivation is dependent on homeodomain-DNA binding, the N51S mutation was introduced into the homeodomain of NUP98-HOXA9 (Fig. 2A). The N51 residue of the homeodomain is very highly conserved among different homeobox proteins and is involved in direct homeodomain-DNA binding [21], [22]. Mutation of this residue has been well characterized and shown to abolish the ability of homeobox proteins to bind to DNA [10], [17], [19], [23]. The resulting mutant, NUP98-HOXA9/N51S, was expressed at a level equivalent to NUP98-HOXA9 in K562 cells (Fig. 2B). NUP98-HOXA9/N51S was tested for its effects on transcription from the KBTBD10 and PLN promoters. NUP98-HOXA9/N51S did not transactivate the KBTBD10 promoter (Fig. 3A); but surprisingly, it was able to transactivate the PLN promoter to the same extent as NUP98-HOXA9 (Fig. 3B). This suggests that NUP98-HOXA9 transactivates the PLN promoter by a mechanism that does not involve direct DNA binding. To confirm this, chromatin immunoprecipitation (ChIP) studies were carried out. First, deletion studies of the KBTBD10 and PLN promoters were used to identify promoter regions responsible for transactivation by NUP98-HOXA9 (Fig. 4A, 4B, and 5A) and PCR primers were chosen for ChIP accordingly (Fig. 5A). Flag-tagged versions of NUP98-HOXA9 and NUP98-HOXA9/N51S were introduced into K562 cells by nucleofection. Chromatin was immunoprecipitated with anti-Flag antibody and the indicated segments of the KBTBD10 and PLN promoters were amplified by PCR. NUP98-HOXA9 showed association with the KBTBD10 promoter whereas NUP98-HOXA9/N51S did not show significant binding (Fig. 5B). Neither NUP98-HOXA9 nor NUP98-HOXA9/N51S showed significant binding to the segment of the PLN promoter that is transactivated by NUP98-HOXA9 (Fig. 5B). There may be very weak binding of NUP98-HOXA9 to the segment amplified by the PLN (3) primer set. However, unlike the binding to the KBTBD10 promoter, this is difficult to distinguish from background and is not affected by the N51S mutation. Therefore it is unlikely to represent direct specific binding of the homeodomain to the promoter, but it could represent a very weak indirect interaction between NUP98-HOXA9 and the PLN promoter that is difficult to detect by our ChIP assays. Overall, the ChIP findings and the results of luciferase assays (Fig. 3A and 3B) show that transactivation of the KBTBD10 promoter correlates with DNA binding whereas transactivation of the PLN promoter does not.
###end p 12
###begin title 13
Expression of the NUP98-HOXA9/N51S mutant in K562 cells.
###end title 13
###begin p 14
(A) Schematic representation of the N51S mutation in the homeodomain of HA-tagged NUP98-HOXA9. FG Repeats: NUP98 FG repeat region; HD: HOXA9 homeodomain. (B) Immunoblotting using anti-HA antibody shows equivalent expression of NUP98-HOXA9 (NH9) and NUP98-HOXA9/N51S (NH9/N51S) in K562 cells.
###end p 14
###begin title 15
Transcriptional regulation by NUP98-HOXA9/N51S.
###end title 15
###begin p 16
###xml 93 100 93 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KBTBD10</italic>
###xml 574 577 574 577 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLN</italic>
###xml 135 138 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 612 615 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
(A) K562 cells were transfected by electroporation with a luciferase construct driven by the KBTBD10 promoter and either empty pTracer/CMV-Bsd vector (Control) or vector expressing NUP98-HOXA9 (NH9) or NUP98-HOXA9/N51S (NH9/N51S). Firefly luciferase activity was measured 48 h after transfection and normalized to a Renilla luciferase internal control. The numbers represent fold change over control (average of 4 independent experiments); error bars represent standard deviation. (B) K562 cells were transfected by electroporation with a luciferase construct driven by the PLN promoter and either empty pTracer/CMV-Bsd vector (Control) or vector expressing NUP98-HOXA9 (NH9) or NUP98-HOXA9/N51S (NH9/N51S). Luciferase activity was measured and plotted as described in A above.
###end p 16
###begin title 17
Identification of promoter sequences responsible for transactivation by NUP98-HOXA9.
###end title 17
###begin p 18
###xml 34 41 34 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KBTBD10</italic>
###xml 257 264 257 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KBTBD10</italic>
###xml 529 532 529 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLN</italic>
###xml 630 633 630 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLN</italic>
###xml 849 852 849 852 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLN</italic>
###xml 306 309 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 894 897 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
(A) The indicated segments of the KBTBD10 promoter were subcloned into the pGL4.11 plasmid upstream of luciferase (LUC). K562 cells were transfected by electroporation with either empty pGL4.11 vector or with vector containing the indicated segments of the KBTBD10 promoter along with either empty pTracer/CMV-Bsd vector (Control) or vector expressing NUP98-HOXA9 (NH9). Luciferase activity was measured and plotted as described in 3A above. The numbers represent the averages of 3 independent experiments. (B) Identification of PLN promoter sequences responsible for transactivation by NUP98-HOXA9. The indicated segments of the PLN promoter were subcloned into the pGL4.11 plasmid upstream of luciferase (LUC). K562 cells were transfected by electroporation with either empty pGL4.11 vector or with vector containing the indicated segments of the PLN promoter along with either empty pTracer/CMV-Bsd vector (Control) or vector expressing NUP98-HOXA9 (NH9). Luciferase activity was measured and plotted as described in 3A above. The numbers represent the averages of 3 independent experiments.
###end p 18
###begin title 19
Chromatin immunoprecipitation with NUP98-HOXA9 and NUP98-HOXA9/N51S.
###end title 19
###begin p 20
###xml 30 37 30 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KBTBD10</italic>
###xml 42 45 42 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLN</italic>
###xml 111 117 111 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006719-g004">Fig. 4</xref>
###xml 427 434 427 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KBTBD10</italic>
###xml 439 442 439 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLN</italic>
###xml 302 305 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
(A) Schematic drawings of the KBTBD10 and PLN promoters showing transcriptionally active regions identified in Fig. 4 above. The heavy lines indicate the segments amplified in the ChIP assay. (B) Chromatin was immunoprecipitated with anti-Flag antibody from K562 cells nucleofected with either pTracer/CMV-Bsd vector (control), or vector containing Flag-tagged NUP98-HOXA9 (NH9) or NUP98-HOXA9/N51S (NH9/N51S). Segments of the KBTBD10 and PLN promoters (indicated in 5A above) were amplified by PCR. The upper lanes show immunoprecipitated chromatin (IP) and the lower lanes show input chromatin (Input).
###end p 20
###begin p 21
###xml 128 135 128 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KBTBD10</italic>
###xml 247 250 247 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLN</italic>
Taken together, these data suggest that NUP98-HOXA9 modulates transcription by at least two mechanisms: one, exemplified by the KBTBD10 promoter, involves direct binding to the promoter through the homeodomain; while the other, exemplified by the PLN promoter, does not involve DNA binding.
###end p 21
###begin title 22
###xml 45 50 <span type="species:ncbi:9606">human</span>
Disruption of the differentiation of primary human CD34+ cells by NUP98-HOXA9 does not require homeodomain-DNA binding
###end title 22
###begin p 23
###xml 402 406 402 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Takeda1">[15]</xref>
###xml 737 744 733 740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006719-g006">Fig. 6A</xref>
###xml 828 835 824 831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006719-g006">Fig. 6B</xref>
###xml 216 221 <span type="species:ncbi:9606">human</span>
###xml 370 375 <span type="species:ncbi:9606">human</span>
###xml 538 543 <span type="species:ncbi:9606">human</span>
###xml 809 814 <span type="species:ncbi:9606">human</span>
###xml 941 946 <span type="species:ncbi:9606">human</span>
The data described above showed that NUP98-HOXA9 can disrupt gene expression by mechanisms that do not require DNA binding. It was not clear, however, whether such mechanisms contribute to leukemic transformation of human primary CD34+ cells by NUP98-HOXA9. We have previously shown that NUP98-HOXA9 interferes with both erythroid and myeloid differentiation of primary human CD34+ hematopoietic cells [15]. To determine the relative contributions of the NUP98 and HOXA9 moieties to disruption of hematopoietic differentiation of primary human CD34+ cells by NUP98-HOXA9, retroviral vectors were prepared that express NUP98-HOXA9, wild-type HOXA9, NUP98-HOXA9/N51S, and a mutant of NUP98-HOXA9 that lacks the NUP98 moiety (HOXA9DeltaN) (Fig. 6A). All constructs expressed comparable protein levels in primary human CD34+ cells (Fig. 6B). The effects of NUP98-HOXA9, NUP98-HOXA9/N51S, HOXA9, and HOXA9DeltaN on the differentiation of primary human CD34+ cells were compared to those of empty vector. Differentiation was assessed by colony-forming cell (CFC) assays combined with morphologic evaluation and flow cytometric immunophenotyping.
###end p 23
###begin title 24
###xml 35 40 <span type="species:ncbi:9606">human</span>
Retroviral transduction of primary human CD34+ cells.
###end title 24
###begin p 25
###xml 268 273 <span type="species:ncbi:9606">human</span>
(A) HA-tagged NUP98-HOXA9, NUP98-HOXA9/N51S, HOXA9, or HOXA9DeltaN open reading frames were subcloned into the MSCV-IRES-GFP vector. LTR: long terminal repeat; IRES: internal ribosomal entry site; FG Repeats: NUP98 FG repeat region; HD: HOXA9 homeodomain. (B) Primary human CD34+ cells were transduced with the retroviral vectors and sorted for GFP expression; protein expression was verified by immunoblotting with anti-HA antibody. NH9: NUP98-HOXA9; NH9/N51S: NUP98-HOXA9/N51S; H9: HOXA9; H9DeltaN: HOXA9DeltaN.
###end p 25
###begin p 26
###xml 23 27 23 27 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Takeda1">[15]</xref>
###xml 158 164 158 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006719-g007">Fig. 7</xref>
###xml 413 419 413 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006719-g007">Fig. 7</xref>
###xml 547 553 543 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006719-g007">Fig. 7</xref>
As previously reported [15], inspection of CFC plates without magnification showed many prominent large erythroid colonies in samples expressing NUP98-HOXA9 (Fig. 7). The large colonies included some with decreased hemoglobinization, indicating incomplete erythroid maturation. Cells expressing NUP98-HOXA9/N51S gave rise to a similar macroscopic appearance but with more fully hemoglobinized erythroid colonies (Fig. 7). In contrast, cells expressing either HOXA9 or HOXA9DeltaN did not give rise to macroscopically prominent erythroid colonies (Fig. 7).
###end p 26
###begin title 27
###xml 57 62 <span type="species:ncbi:9606">human</span>
NUP98-HOXA9 and NUP98-HOXA9/N51S have similar effects on human CFC morphology.
###end title 27
###begin p 28
###xml 8 13 <span type="species:ncbi:9606">human</span>
Primary human CD34+ cells were retrovirally transduced with either control MSCV-IRES-GFP vector or vector expressing NUP98-HOXA9, NUP98-HOXA9/N51S, HOXA9, or HOXA9DeltaN, and cells were sorted for GFP positivity. One thousand cells were seeded into each of two duplicate plates for CFC assay and the experiment was repeated 3-4 independent times. Representative plates without magnification (left) and low power photomicrographs of representative erythroid colonies (right) are shown.
###end p 28
###begin p 29
###xml 167 173 167 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006719-g008">Fig. 8</xref>
###xml 217 223 217 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006719-g009">Fig. 9</xref>
###xml 374 381 370 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0006719-t001">Table 1</xref>
###xml 543 550 539 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0006719-t001">Table 1</xref>
###xml 590 596 586 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006719-g008">Fig. 8</xref>
To further assess erythroid differentiation, cells were harvested from the CFC plates and subjected to morphologic evaluation on Giemsa-stained Cytospin preparations (Fig. 8) and to flow cytometric immunophenotyping (Fig. 9). The total number of cells per plate was increased in the NUP98-HOXA9 and the NUP98-HOXA9/N51S samples but not in the HOXA9 and HOXA9DeltaN samples (Table 1). A 500-cell differential count was carried out on the Giemsa-stained slides from each sample; the average numbers from 3-4 independent experiments are shown in Table 1 and representative fields are shown in Fig. 8. There was a marked increase in the numbers of erythroid cells with a shift to immaturity in the NUP98-HOXA9 sample. Erythroid cells were also markedly increased in the NUP98-HOXA9/N51S sample, but without a statistically significant morphologic shift to immaturity. Erythroid cell number and morphology in the HOXA9 and HOXA9DeltaN samples were not significantly different from the control sample.
###end p 29
###begin title 30
Cell morphology shows homeodomain-independent disruption of differentiation by NUP98-HOXA9.
###end title 30
###begin p 31
###xml 51 57 51 57 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006719-g007">Fig. 7</xref>
###xml 219 226 219 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0006719-t001">Table 1</xref>
Cytospin smears were prepared from CFC plates (see Fig. 7 above) and stained with Giemsa. Photomicrographs were taken from representative fields with a 60xoil objective. For quantitation of the different cell types see Table 1. B: blast; MM: mature myeloid, IM: intermediate myeloid, ME: mature erythroid, IE: intermediate erythroid.
###end p 31
###begin title 32
Dissection of the effects of NUP98-HOXA9 on hematopoietic differentiation based on cell morphology.
###end title 32
###begin p 33
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
P<0.05.
###end p 33
###begin p 34
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
P<0.01.
###end p 34
###begin p 35
###xml 754 755 750 751 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Averages from 3-4 independent experiments are shown; cells from 2 CFC plates for each experimental condition were harvested. The bottom line shows the average total cell numbers in the two plates+/-standard deviations. Cytospins smears were prepared and stained with Giemsa; a 500 cell differential count was performed. Cells with blast and promyelocyte morphology were counted as primitive; those with myelocyte/metamyelocyte morphology as intermediate myeloid; those with band, segmented neutrophil, monocyte, and macrophage morphology as mature myeloid; those with intermediate hemoglobinization as intermediate erythroid; and those with full hemoglobinization as mature erythroid. The first 5 rows show average percentages+/-standard deviations. The P value was obtained by comparing to control using a paired two-tailed distribution t-test.
###end p 35
###begin p 36
###xml 221 228 221 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006719-g009">Fig. 9A</xref>
To evaluate erythroid differentiation by flow cytometry, erythroid cells were gated based on CD235a (Glycophorin A) positivity, and plotted on a histogram to show the level of CD235a expression relative to control cells (Fig. 9A). The expression level of CD235a was decreased in cells expressing NUP98-HOXA9 and NUP98-HOXA9/N51S, indicating disrupted erythroid differentiation. In contrast, no significant reduction in CD235a expression was seen in cells expressing HOXA9 and HOXA9DeltaN.
###end p 36
###begin title 37
###xml 59 64 <span type="species:ncbi:9606">human</span>
Flow cytometry shows homeodomain-independent disruption of human primary CD34+ cell differentiation by NUP98-HOXA9.
###end title 37
###begin p 38
###xml 81 87 81 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006719-g007">Fig. 7</xref>
###xml 356 362 356 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006719-g007">Fig. 7</xref>
(A) Flow cytometry for erythroid differentiation: Cells from the CFC plates (see Fig. 7 above) were harvested and stained with antibodies to CD45 and CD235a. The CD235a+ gate was plotted on a histogram (lower panels) to show the expression of CD235a relative to control cells. (B) Flow cytometry for myeloid differentiation: Cells from the CFC plates (see Fig. 7 above) were harvested and stained with CD45, CD33 and CD11b; the CD33+ gate was plotted on a histogram to show CD11b expression compared to control (lower panels). The percentages of cells falling within each gate are shown.
###end p 38
###begin p 39
###xml 204 211 204 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0006719-t001">Table 1</xref>
###xml 282 288 282 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006719-g008">Fig. 8</xref>
###xml 477 484 477 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0006719-t001">Table 1</xref>
Myeloid differentiation was also assessed by morphologic evaluation of Giemsa-stained Cytospin preparations and flow cytometric immunophenotyping. The results of 500-cell differential counts are shown in Table 1 and representative fields from the Giemsa-stained slides are shown in Fig. 8. The percentage of mature myeloid cells was markedly decreased in the NUP98-HOXA9 samples, moderately decreased in the NUP98-HOXA9/N51S samples, and mildly decreased in the HOXA9 samples (Table 1). Primitive cells were markedly increased in the NUP98-HOXA9 samples and mildly increased in the HOXA9 samples. The latter also showed a significant increase in the numbers of myeloid cells with intermediate differentiation. NUP98-HOXA9/N51S caused a mild increase in the numbers of primitive cells, but the change did not reach statistical significance. HOXA9DeltaN did not cause a significant change in myeloid cell morphology.
###end p 39
###begin p 40
###xml 172 179 172 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006719-g009">Fig. 9B</xref>
For flow cytometric evaluation of myeloid differentiation, myeloid cells (CD33+) were gated and the level of CD11b expression was compared to control cells on a histogram (Fig. 9B). Both NUP98-HOXA9 and NUP98-HOXA9/N51S caused a prominent decrease in the expression of CD11b, consistent with a block in myeloid differentiation. In contrast, HOXA9 and HOXA9DeltaN did not significantly alter the expression of CD11b.
###end p 40
###begin p 41
###xml 139 146 135 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0006719-t002">Table 2</xref>
###xml 103 108 <span type="species:ncbi:9606">human</span>
###xml 551 556 <span type="species:ncbi:9606">human</span>
The effects of NUP98-HOXA9, NUP98-HOXA9/N51S, HOXA9, and HOXA9DeltaN on the differentiation of primary human CD34+ cells are summarized in Table 2. The ability of NUP98-HOXA9/N51S to recapitulate most of the effects of NUP98-HOXA9 suggests that the disruption of hematopoietic differentiation by NUP98-HOXA9 is largely attributable to the NUP98 moiety and does not require DNA binding by the homeodomain. The fact that the isolated HOXA9 moiety (HOXA9DeltaN) had no effect on differentiation shows that the NUP98 moiety is necessary for disruption of human hematopoietic differentiation. This is further confirmed by the observation that wild-type HOXA9 had only a mild effect on differentiation in spite of containing both the homeodomain and a transactivating domain.
###end p 41
###begin title 42
###xml 132 137 <span type="species:ncbi:9606">human</span>
Summary of the effects of NUP98-HOXA9, NUP98-HOXA9/N51S, HOXA9, and HOXA9DeltaN on the differentiation and proliferation of primary human CD34+ cells.
###end title 42
###begin p 43
NC indicates no change.
###end p 43
###begin title 44
###xml 87 92 <span type="species:ncbi:9606">human</span>
The two moieties of NUP98-HOXA9 act synergistically to induce proliferation of primary human CD34+ cells
###end title 44
###begin p 45
###xml 91 95 91 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Takeda1">[15]</xref>
###xml 97 101 97 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Chung1">[16]</xref>
###xml 566 570 562 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Takeda1">[15]</xref>
###xml 607 615 603 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006719-g010">Fig. 10A</xref>
###xml 55 60 <span type="species:ncbi:9606">human</span>
###xml 304 309 <span type="species:ncbi:9606">human</span>
NUP98-HOXA9 induces long-term proliferation of primary human CD34+ cells in liquid culture [15], [16]. In order to assess the relative contributions of the NUP98 and HOXA9 moieties to this proliferative effect, NUP98-HOXA9, NUP98-HOXA9/N51S, wild-type HOXA9, and HOXA9DeltaN were introduced into primary human CD34+ hematopoietic cells by retroviral transduction, with empty retroviral vector as a control. Cells expressing the transduced constructs were selected by sorting for GFP and were cultured in liquid media with a cytokine cocktail as previously described [15] with periodic feeding and counting (Fig. 10A). The different samples showed similar growth profiles for approximately the first month, after which the numbers of control cells and cells expressing HOXA9DeltaN began to decline. Cells expressing HOXA9 or NUP98-HOXA9/N51S showed a modest degree of growth for another few weeks before beginning to decline as well. As expected, NUP98-HOXA9 induced a marked increase in the number of cells in long-term liquid culture that was several orders of magnitude more than that of control cells.
###end p 45
###begin title 46
###xml 82 87 <span type="species:ncbi:9606">human</span>
The two moieties of NUP98-HOXA9 synergistically increase proliferation of primary human CD34+ cells.
###end title 46
###begin p 47
###xml 8 13 <span type="species:ncbi:9606">human</span>
Primary human CD34+ cells were retrovirally transduced with either control MSCV-IRES-GFP vector or vector expressing NUP98-HOXA9 (NH9), NUP98-HOXA9/N51S (NH9/N51S), HOXA9 (H9), or HOXA9DeltaN (H9DeltaN), and cells were sorted for GFP positivity. (A) The cumulative fold increase in cell numbers compared to day 0 is plotted on a logarithmic scale against time. The experiment was repeated 3 times; results from a representative experiment are shown. (B) LTC-IC assay showing the average fold change compared to control from 3 independent experiments. The error bars represent standard deviations.
###end p 47
###begin p 48
###xml 243 247 243 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Sutherland1">[24]</xref>
###xml 269 273 269 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Takeda1">[15]</xref>
###xml 334 342 334 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006719-g010">Fig. 10B</xref>
###xml 497 501 493 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Kroon1">[12]</xref>
###xml 553 561 549 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 561 565 557 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Calvo2">[17]</xref>
###xml 35 40 <span type="species:ncbi:9606">human</span>
###xml 492 496 <span type="species:ncbi:10090">mice</span>
###xml 527 532 <span type="species:ncbi:10090">mouse</span>
###xml 634 639 <span type="species:ncbi:9606">human</span>
Long-term proliferation of primary human CD34+ cells in liquid culture is usually associated with an increase in the numbers of primitive self-renewing cells. These cells are quantitated by the long-term culture-initiating cell (LTC-IC) assay [24]. As previously shown [15], NUP98-HOXA9 induced an increase in the numbers of LTC-ICs (Fig. 10B). On the other hand, NUP98-HOXA9/N51S, HOXA9, and HOXA9DeltaN did not cause an increase in the numbers of LTC-ICs. Although HOXA9 is leukemogenic in mice [12] and immortalizes primary mouse hematopoietic cells in vitro[17], our data suggest that it does not have a similar effect on primary human hematopoietic cells.
###end p 48
###begin p 49
###xml 137 144 133 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0006719-t002">Table 2</xref>
###xml 101 106 <span type="species:ncbi:9606">human</span>
The effects of NUP98-HOXA9, NUP98-HOXA9/N51S, HOXA9, and HOXA9DeltaN on the proliferation of primary human CD34+ cells are summarized in Table 2. The modest increase in cell numbers induced by NUP98-HOXA9/N51S and HOXA9 in long-term culture compared to controls may reflect increased cell survival with a slight increase in proliferation. The data suggest that the effect of NUP98-HOXA9 on cell numbers is partially dependent on classical transactivation involving DNA binding and partially on mechanisms other than DNA binding. The two mechanisms appear to act synergistically since the effect of NUP98-HOXA9 on long-term proliferation and the number of LTC-ICs is more than the sum of the separate effects of HOXA9 and NUP98-HOXA9/N51S.
###end p 49
###begin title 50
###xml 66 71 <span type="species:ncbi:9606">human</span>
Homeodomain-independent gene regulation by NUP98-HOXA9 in primary human CD34+ cells
###end title 50
###begin p 51
###xml 790 799 786 795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006719.s002">Tables S2</xref>
###xml 801 803 797 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006719.s003">S3</xref>
###xml 805 807 801 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006719.s004">S4</xref>
###xml 809 811 805 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006719.s005">S5</xref>
###xml 826 834 822 830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006719-g011">Fig. 11A</xref>
###xml 1000 1008 992 1000 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006719-g011">Fig. 11A</xref>
###xml 1086 1096 1078 1088 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s3">Discussion</xref>
###xml 1269 1279 1261 1271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s3">Discussion</xref>
###xml 1302 1306 1294 1298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HEY1</italic>
###xml 1382 1385 1374 1377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Ghannam1">[6]</xref>
###xml 1421 1425 1413 1417 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HEY1</italic>
###xml 1435 1439 1427 1431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Maier1">[25]</xref>
###xml 1441 1445 1433 1437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Zavadil1">[26]</xref>
###xml 1522 1530 1514 1522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006719-g011">Fig. 11B</xref>
###xml 1585 1589 1577 1581 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HEY1</italic>
###xml 1727 1735 1719 1727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006719-g011">Fig. 11A</xref>
###xml 80 85 <span type="species:ncbi:9606">human</span>
###xml 320 325 <span type="species:ncbi:9606">human</span>
###xml 588 593 <span type="species:ncbi:9606">Human</span>
The data described above show that disruption of the differentiation of primary human CD34+ cells by NUP98-HOXA9 is to a large extent independent of DNA binding by the homeodomain. To identify changes in gene expression that underlie this disrupted differentiation, expression microarray analysis was performed. Primary human CD34+ cells were transduced with retroviral vectors expressing NUP98-HOXA9, NUP98-HOXA9/N51S, wild-type HOXA9, and HOXA9DeltaN as well as control empty vector, and were sorted for GFP expression. RNA was isolated from the cells and analyzed using the Affymetrix Human genome U133+2.0 array. The experiment was performed two independent times, and lists of probe sets showing a difference of 1.74-fold or more compared to control in both experiments were compiled (Tables S2, S3, S4, S5). As shown in Fig. 11A, 46 of the probe sets showed dysregulation by both NUP98-HOXA9 and NUP98-HOXA9/N51S. Some of these overlap probe sets showed dysregulation by HOXA9 and HOXA9DeltaN (Fig. 11A) suggesting dysregulation by mechanisms involving homeodomain sequences (see Discussion). The remaining 26 probe sets represent 23 unique genes are dysregulated by mechanisms that require the NUP98 moiety but are apparently independent of the homeodomain (see Discussion). One of these genes, HEY1, is also dysregulated in K562 cells by retrovirally transduced NUP98-HOXA9 [6]. A ChIP assay was performed on the HEY1 promoter [25], [26] in K562 cells expressing either NUP98-HOXA9 or its N51S mutant. As shown in Fig. 11B, neither NUP98-HOXA9 nor its N51S mutant bound to the HEY1 promoter, supporting the notion that its transactivation is independent of direct homeodomain-DNA interaction. Among the genes listed in Fig. 11A, a few are notable for functions that may explain the transforming activities shared by NUP98-HOXA9 and NUP98-HOXA9/N51S:
###end p 51
###begin title 52
###xml 66 71 <span type="species:ncbi:9606">human</span>
Homeodomain-independent gene regulation by NUP98-HOXA9 in primary human CD34+ cells.
###end title 52
###begin p 53
###xml 1221 1225 1205 1209 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HEY1</italic>
###xml 1261 1282 1245 1266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 12 17 <span type="species:ncbi:9606">human</span>
###xml 1095 1098 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
(A) Primary human CD34+ cells were retrovirally transduced with either control MSCV-IRES-GFP vector or vector expressing NUP98-HOXA9 (NH9), NUP98-HOXA9/N51S (NH9/N51S), HOXA9 (H9), or HOXA9DeltaN (H9DeltaN). Cells were sorted for GFP positivity and total RNA was subjected to microarray analysis. The experiment was performed two independent times and only genes that showed up- or down-regulation by 1.74 fold or more compared to control in both experiments were considered dysregulated. As shown in the upper Venn diagram, 46 probe sets showed dysregulation by both NUP98-HOXA9 (NH9) and NUP98-HOXA9/N51S (NH9/N51S). Of these, 26 did not show dysregulation by either HOXA9DeltaN (H9DeltaN) or HOXA9 (H9) and were considered homeodomain-independent (lower Venn diagram). These 26 probe sets represent 23 unique genes listed on the left. Genes with a potential role in homeodomain-independent transforming functions of NUP98-HOXA9 are highlighted in red and are discussed in the text. (B) Chromatin was immunoprecipitated with anti-Flag antibody from K562 cells nucleofected with either pTracer/CMV-Bsd vector (control), or vector containing Flag-tagged NUP98-HOXA9 (NH9) or NUP98-HOXA9/N51S (NH9/N51S). A segment of the HEY1 promoter was amplified by PCR (see Materials and Methods for primer sequences). The upper lanes show immunoprecipitated chromatin (IP) and the lower lanes show input chromatin (Input).
###end p 53
###begin title 54
RAP1A
###end title 54
###begin p 55
###xml 208 212 208 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Kitayama1">[27]</xref>
###xml 322 326 322 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Stork1">[28]</xref>
###xml 418 422 418 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Stork1">[28]</xref>
###xml 511 515 511 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Stork2">[29]</xref>
###xml 635 639 635 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Adachi1">[30]</xref>
###xml 641 645 641 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Garcia1">[31]</xref>
###xml 755 759 755 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Balduini1">[32]</xref>
###xml 1019 1023 1019 1023 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Garcia1">[31]</xref>
###xml 1025 1029 1025 1029 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Delehanty1">[33]</xref>
###xml 1077 1081 1077 1081 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Arai1">[34]</xref>
###xml 689 694 <span type="species:ncbi:9606">human</span>
This gene was downregulated by NUP98-HOXA9 and NUP98-HOXA9/N51S. It encodes a small GTPase of the Ras family that was identified as a suppressor of the transforming activity of oncogenic Ras in NIH/3T3 cells [27]. It was subsequently found to potentiate the functions of Ras in some cells and to antagonize them in others [28]. RAP1A functions in integrin-mediated adhesion and signaling and in the MAP kinase cascade [28]. It plays various roles in the proliferation and differentiation of hematopoietic cells [29]. For example, megakaryocytic, monocytic, and lymphoid differentiation of cell lines is associated with RAP1A induction [30], [31]. Maturation of megakaryocytes derived from human cord blood cells is also associated with induction of RAP1A [32]. Thrombopoietin-induced megakaryocytic differentiation is mediated by sustained activation of the ERK/MAPK pathway mediated by RAP1A activation and inhibition of megakaryocytic differentiation by stromal contact is associated with a block in RAP1A activation [31], [33]. Finally, RAP1A is activated by erythropoietin [34], raising the possibility that it plays a role in erythroid differentiation. Based on these data, the repression of RAP1A expression by both NUP98-HOXA9 and NUP98-HOXA9/N51S may play a role in their inhibition of both erythroid and myeloid differentiation.
###end p 55
###begin title 56
PTGS2
###end title 56
###begin p 57
###xml 309 310 309 310 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 316 317 316 317 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 383 387 383 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Ulrich1">[35]</xref>
###xml 608 612 608 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Ulrich1">[35]</xref>
###xml 807 811 807 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Harris1">[36]</xref>
###xml 1028 1032 1028 1032 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Bernard1">[37]</xref>
###xml 1202 1206 1202 1206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Robak1">[38]</xref>
###xml 1314 1318 1314 1318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Pogoda1">[39]</xref>
###xml 1393 1397 1393 1397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Romana1">[18]</xref>
###xml 1438 1443 1438 1443 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTGS2</italic>
###xml 1551 1559 <span type="species:ncbi:9606">patients</span>
This gene was upregulated by NUP98-HOXA9 and NUP98-HOXA9/N51S. It encodes prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase 2), better known as cyclooxygenase-2 (COX-2). It is one of two isozymes, COX-1 and COX-2, that are responsible for the conversion of arachidonic acid to prostaglandins G2 and H2, which in turn give rise to a number of different prostaglandins [35]. COX-1 is constitutively expressed, whereas COX-2 is inducible and is overexpressed in many tumors resulting in overproduction of prostaglandins, including PGE2, which appears to play an important role in carcinogenesis [35]. Many types of cancer are known to overexpress COX-2 and there is a great deal of evidence that COX-2 inhibition with drugs such as aspirin can be used in the prevention and treatment of cancer [36]. A number of hematopoietic malignancies, including chronic myleogenous leukemia, chronic lymphocytic leukemia, lymphomas, and myeloma, have been shown to overexpress COX-2, which is associated with a worse prognosis [37]. There is evidence that the use of aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) is associated with a lower incidence of lymphomas and acute leukemia [38]. NSAID use has been found to reduce the risk of AML, particularly the FAB M2 subtype (AML with maturation) [39], which is the most common subtype in cases with NUP98 gene rearrangements [18]. Our data suggest that the induction of PTGS2 expression by NUP98-HOXA9 is mediated by the NUP98 moiety and may contribute to the worse prognosis of AML patients with NUP98 gene rearrangements. It is possible that COX-2 blockade could help in the treatment of these leukemias.
###end p 57
###begin title 58
HEY1
###end title 58
###begin p 59
###xml 25 30 25 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HERP2</italic>
###xml 208 212 208 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Iso1">[40]</xref>
###xml 354 358 354 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Cavard1">[41]</xref>
###xml 360 364 360 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Engin1">[42]</xref>
###xml 366 370 366 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Hulleman1">[43]</xref>
###xml 372 376 372 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Kang1">[44]</xref>
###xml 378 382 378 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Konishi1">[45]</xref>
###xml 384 388 384 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Lucas1">[46]</xref>
###xml 491 495 491 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Moore1">[47]</xref>
###xml 611 615 611 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Nefedova1">[48]</xref>
###xml 1028 1032 1028 1032 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Henning1">[49]</xref>
###xml 1164 1168 1164 1168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Elagib1">[50]</xref>
###xml 908 913 <span type="species:ncbi:10090">mouse</span>
###xml 1053 1058 <span type="species:ncbi:9606">human</span>
###xml 1436 1441 <span type="species:ncbi:9606">human</span>
This gene (also known as HERP2) was upregulated by NUP98-HOXA9 and NUP98-HOXA9/N51S. It is a b-HLH protein that acts as a transcriptional repressor. It is an important mediator in the Notch signaling pathway [40] and has been implicated in the pathogenesis of several types of cancer including tumors of the brain, lung, pancreas, bone, skin, and kidney [41], [42], [43], [44], [45], [46]. Notch signaling is thought to play an important role in the self-renewal of hematopoietic stem cells [47] and plays an important role in the pathogenesis of hematologic malignancies, particularly T-lymphoblastic leukemia [48]. While the role of Notch signaling in AML is not well established, these data suggest that upregulation of HEY1 may contribute to the long-term proliferation and increased numbers of LTC-ICs induced by NUP98-HOXA9. There is evidence for involvement of HEY1 in erythroid differentiation: in a mouse cell line, Notch signaling associated with HEY1 upregulation resulted in increased the numbers of erythroid cells [49], whereas in primary human hematopoietic cells upregulation of HEY1 by JUN was associated with a block in erythroid differentiation [50]. The somewhat different results obtained in these two studies may reflect the different experimental systems used, but the data nevertheless suggest that the increased numbers of erythroid cells and the disrupted erythroid differentiation that we observed in primary human cells expressing NUP98-HOXA9 or NUP98-HOXA9/N51S may be mediated at least in part by upregulation of HEY1.
###end p 59
###begin title 60
Discussion
###end title 60
###begin p 61
###xml 269 274 <span type="species:ncbi:9606">human</span>
The luciferase reporter and ChIP data in K562 cells demonstrate at least two modes by which the NUP98-HOXA9 oncogene can dysregulate gene transcription: one that correlates with DNA-binding through the HOXA9 homeodomain and another that does not. The data from primary human CD34+ cells show that the latter mode is necessary and sufficient for most of the effects of NUP98-HOXA9 on differentiation.
###end p 61
###begin p 62
###xml 314 321 310 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006719.s006">Fig. S1</xref>
###xml 499 503 495 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Denning1">[51]</xref>
###xml 505 509 501 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Denning2">[52]</xref>
###xml 811 819 803 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006719-g011">Fig. 11A</xref>
###xml 824 833 816 825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006719.s002">Tables S2</xref>
###xml 834 836 826 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006719.s005">S5</xref>
###xml 1012 1020 1000 1008 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006719-g011">Fig. 11A</xref>
###xml 1175 1179 1163 1167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Shen1">[53]</xref>
###xml 1457 1460 1445 1448 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLN</italic>
###xml 1689 1697 1677 1685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006719-g011">Fig. 11A</xref>
###xml 2116 2120 2104 2108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Fontoura1">[54]</xref>
###xml 2122 2126 2110 2114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Radu1">[55]</xref>
###xml 2128 2132 2116 2120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Yaseen1">[56]</xref>
###xml 2247 2251 2235 2239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Pritchard1">[57]</xref>
The mechanisms by which NUP98-HOXA9/N51S modulates gene expression remain to be determined. An isolated NUP98 moiety (NUP98DeltaC) that comprises the FG repeat region of NUP98 caused a mild disruption of myeloid differentiation, but did not have a significant effect on erythroid differentiation or proliferation (Fig. S1). This suggests that the FG repeat region may not be entirely sufficient for the disruption of differentiation. However, nucleoporin FG repeat regions are inherently disordered [51], [52] and it is likely that NUP98DeltaC would misfold, mislocalize, and/or lose important protein-protein interactions making the results difficult to interpret. Based on gene expression analysis, a group of 46 probe sets were identified that show similar dysregulation by NUP98-HOXA9 and NUP98-HOXA9/N51S (Fig. 11A and Tables S2-S5) and therefore presumably do not require direct DNA binding by the homeodomain for their dysregulation. Some of these genes are also dysregulated by HOXA9 and/or HOXA9DeltaN (Fig. 11A), suggesting that their dysregulation is mediated by non-DNA-binding parts of the homeodomain such as those that mediate dimerization with other proteins [53]. One possibility is that the homeodomain would interact with promoters indirectly by dimerizing with another DNA-binding factor. Such indirect binding may be difficult to detect with our ChIP assays and cannot be entirely excluded as a mechanism for the transactivation of the PLN promoter. Another possibility is that the homeodomain may disrupt transcription by titrating away transcription factors through dimerization. The remaining 26 probes represent 23 genes that appear to be homeodomain-independent (Fig. 11A) and their dysregulation requires the NUP98 moiety of NUP98-HOXA9. Based on the functions of the NUP98 moiety, an intriguing possibility is that expression of these genes may be dysregulated by a disruption in nucleocytoplasmic transport. The NUP98 portion of NUP98 fusions contains most or all of its FG repeats, which interact with nuclear transport carriers that mediate the nucleocytoplasmic transport of proteins [54], [55], [56]. It also contains the GLEBS motif that plays a role in RNA export by interacting with the mRNA export factor RAE1 [57]. Therefore homeodomain-independent functions of NUP98-HOXA9 (and other NUP98 fusions) may be mediated by disruption of the nucleocytoplasmic transport of transcription factors or RNAs that are important in myeloid differentiation and proliferation. Future experiments directed at identifying proteins that interact with NUP98-HOXA9 and examining its effects on nucleocytoplasmic transport may elucidate the homeodomain-independent mechanisms that contribute to the leukemogenic functions of NUP98 fusion proteins.
###end p 62
###begin p 63
###xml 231 239 231 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 239 243 239 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Kroon1">[12]</xref>
###xml 245 249 245 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Calvo2">[17]</xref>
###xml 315 319 315 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Bullinger1">[58]</xref>
###xml 321 325 321 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Drabkin1">[59]</xref>
###xml 327 331 327 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Kawagoe1">[60]</xref>
###xml 333 337 333 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Lawrence1">[61]</xref>
###xml 865 873 865 873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0006719-t001">Tables 1</xref>
###xml 878 879 878 879 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0006719-t002">2</xref>
###xml 1039 1046 1039 1046 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006719-g011">Fig. 11</xref>
###xml 81 86 <span type="species:ncbi:9606">human</span>
###xml 133 137 <span type="species:ncbi:10090">mice</span>
###xml 205 210 <span type="species:ncbi:10090">mouse</span>
###xml 305 310 <span type="species:ncbi:9606">human</span>
###xml 362 367 <span type="species:ncbi:9606">human</span>
###xml 480 485 <span type="species:ncbi:9606">human</span>
###xml 550 554 <span type="species:ncbi:10090">mice</span>
###xml 652 657 <span type="species:ncbi:9606">human</span>
###xml 913 918 <span type="species:ncbi:9606">human</span>
We also report here for the first time the effects of wild-type HOXA9 on primary human hematopoietic cells. HOXA9 is leukemogenic in mice, and it causes proliferation and blocks differentiation in primary mouse hematopoietic cells in vitro[12], [17]. While wild-type HOXA9 is overexpressed in a subset of human AML [58], [59], [60], [61], its effects on primary human hematopoietic cell differentiation and proliferation have not been previously reported, and its contribution to human myeloid leukemogenesis is not clear. In contrast to findings in mice, our data show that HOXA9 has modest effects on the proliferation and differentiation of primary human CD34+ cells. It causes a mild increase in the numbers of cells in long-term liquid culture and a mild block in myeloid maturation that is best appreciated on morphologic examination of Giemsa-stained cells (Tables 1 and 2). Microarray analysis of primary human CD34+ cells shows that HOXA9 dysregulates genes recognized by 659 probe sets compared to only 203 for NUP98-HOXA9/N51S (Fig. 11). It is therefore remarkable that NUP98-HOXA9/N51S causes a much more pronounced disruption of differentiation than HOXA9.
###end p 63
###begin p 64
###xml 358 364 358 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006719-g008">Fig. 8</xref>
###xml 369 376 369 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0006719-t001">Table 1</xref>
###xml 576 583 576 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006719-g009">Fig. 9B</xref>
###xml 729 735 729 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006719-g008">Fig. 8</xref>
###xml 740 747 740 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0006719-t001">Table 1</xref>
###xml 876 883 876 883 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006719-g009">Fig. 9A</xref>
It is of interest to note that different differentiation markers did not give identical estimates of the extent of differentiation in our samples. For example, HOXA9 expression clearly decreased the numbers of mature myeloid cells and increased the numbers of less mature myeloid cells as judged by morphologic examination of Giemsa-stained Cytospin smears (Fig. 8 and Table 1). These findings are consistent with a block in myeloid maturation; yet flow cytometry did not reveal a significant difference in the expression of CD11b between HOXA9-expressing cells and controls (Fig. 9B). On the other hand, cells expressing NUP98-HOXA9/N51S did not show morphologic evidence of erythroid immaturity in Giemsa-stained preparations (Fig. 8 and Table 1); yet a clear block in erythroid differentiation was observed by flow cytometry as evidenced by decreased expression of CD235a (Fig. 9A). Thus, a combination of morphology and immunophenotyping can uncover subtle defects in hematopoietic differentiation that may not be otherwise obvious.
###end p 64
###begin title 65
Materials and Methods
###end title 65
###begin title 66
Plasmid construction
###end title 66
###begin p 67
###xml 88 92 88 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Takeda1">[15]</xref>
###xml 157 160 157 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bgl</italic>
###xml 163 166 163 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xba</italic>
###xml 246 248 246 248 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">st</sup>
###xml 406 409 406 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Ghannam1">[6]</xref>
###xml 444 447 440 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Kasper1">[4]</xref>
###xml 708 713 704 709 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HOXB6</italic>
###xml 733 736 729 732 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">JUN</italic>
###xml 756 763 752 759 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KBTBD10</italic>
###xml 783 786 779 782 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLN</italic>
###xml 810 818 806 814 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SERPINE1</italic>
###xml 949 952 945 948 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nhe</italic>
###xml 954 957 950 953 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Eco</italic>
###xml 970 975 966 971 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HOXB6</italic>
###xml 977 980 973 976 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">JUN</italic>
###xml 986 993 982 989 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KBTBD10</italic>
###xml 1009 1012 1005 1008 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kpn</italic>
###xml 1014 1017 1010 1013 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xho</italic>
###xml 1033 1036 1029 1032 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLN</italic>
###xml 1055 1058 1051 1054 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xho</italic>
###xml 1060 1063 1056 1059 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Eco</italic>
###xml 1076 1084 1072 1080 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SERPINE1</italic>
###xml 1112 1119 1108 1115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KBTBD10</italic>
###xml 1124 1127 1120 1123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLN</italic>
###xml 1151 1165 1147 1161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006719-g004">Fig. 4A and 4B</xref>
###xml 12 15 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 578 583 <span type="species:ncbi:9606">human</span>
The pTracer-CMV/Bsd construct expressing HA-tagged NUP98-HOXA9 was previously described [15]. The N51S mutation was created in this construct by replacing a BglII/XbaI fragment with a synthetic fragment containing an A to G substitution in the 51st codon of the homeodomain. The mutation was confirmed by sequencing. MSCV-IRES-GFP constructs expressing HA-tagged NUP98-HOXA9, and HOXA9 have been described [6]. NUP98-HOXA9/N51S and HOXA9DeltaN [4] were subcloned upstream of IRES into MSCV-IRES-GFP. For luciferase constructs, the following promoter regions were amplified from human genomic DNA (Roche, Basel, Switzerland) by PCR using PfuUltra high-fidelity DNA polymerase (Stratagene, La Jolla, CA, USA): HOXB6 from -1934 to +81; JUN from -2013 to +89; KBTBD10 from -2369 to +76; PLN from -1937 to +81; and SERPINE1 from -2012 to +74. PCR products were subcloned into pGL4.11 (Promega, Madison, WI, USA) upstream of the luciferase gene using the NheI/EcoRV sites for HOXB6, JUN, and KBTBD10 promoters; the KpnI/XhoI sites for the PLN promoter; and the XhoI/EcoRV sites for SERPINE1 promoter. Deletions of the KBTBD10 and PLN promoters are shown in Fig. 4A and 4B; they were similarly subcloned into pGL4.11. All sequences generated by PCR were confirmed by DNA sequencing.
###end p 67
###begin title 68
Retrovirus production
###end title 68
###begin p 69
###xml 48 52 48 52 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Takeda1">[15]</xref>
NUP98-HOXA9 retrovirus was previously described [15]. For the remaining retroviruses, GP293 cells were transiently transfected with 4.4 microg of retroviral vector and 1.1 microg of pVSV-G expression vector using Lipofectamine Plus reagent (Invitrogen, Carlsbad, CA, USA). After 48 h, the culture supernatant, containing VSV-pseudotyped retrovirus, was collected and used for transduction of PG13 packaging cells by spinoculation in the presence of 8 microg/mL polybrene (Hexadimethrine Bromide; Sigma-Aldrich Corp., St. Louis, MO, USA). The PG13 culture supernatant containing GaLV-pseudotyped retrovirus was used for transduction of CD34+ primary cells.
###end p 69
###begin title 70
###xml 48 53 <span type="species:ncbi:9606">human</span>
Retroviral transduction and analysis of primary human CD34+ cells
###end title 70
###begin p 71
###xml 476 480 476 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Takeda1">[15]</xref>
###xml 802 806 802 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Takeda1">[15]</xref>
###xml 927 931 927 931 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006719-Takeda1">[15]</xref>
###xml 7 12 <span type="species:ncbi:9606">human</span>
Frozen human CD34+ cells purified from mobilized peripheral blood of two healthy volunteers were obtained from StemCell Technologies (Vancouver, British Columbia, Canada) and the Fred Hutchinson Cancer Research Center (Seattle, WA, USA); and of a deceased autologous transplant donor through the Bone Marrow Transplant Laboratory at Northwestern Memorial Hospital after Institutional Review Board approval. Cells were prestimulated and transduced with retrovirus as described [15]. After 46 h, GFP positive cells were isolated using a MoFlo high-speed sorter (Dako, Glostrup, Denmark) and expression of the transfected gene was confirmed by immunoblotting with anti-HA tag antibody. Long-term liquid culture of primary cells was performed in the presence of a cytokine cocktail as previously described [15]. Colony-forming cell (CFC) and long-term culture-initiating cell (LTC-IC) assays were performed as previously described [15]. Cytospin preparations of cells harvested from the CFC plates were stained with Giemsa and a 500-cell differential count was performed using an Olympus BX51 microscope (Olympus America, Center Valley, PA, USA). Cells with blast and promyelocyte morphology were counted as primitive; those with myelocyte/metamyelocyte morphology as intermediate myeloid; those with band, segmented neutrophil, monocyte, and macrophage morphology as mature myeloid; those with intermediate hemoglobinization as intermediate erythroid; and those with full hemoglobinization as mature erythroid. Photomicrographs were taken with an Olympus DP71 camera with a 60xoil objective.
###end p 71
###begin title 72
Flow cytometry
###end title 72
###begin p 73
Flow cytometry was performed on a FACScan flow cytometer (BD Biosciences, San Jose, CA, USA) upgraded to 5 colors and two lasers, and analyzed using FCS3 Express (De Novo Software, Thornhill, Ontario, Canada) and FlowJO v8.6.3 (Tree Star, Inc., Ashland, OR) software. The antibodies used for these studies were CD11b (phycoerythrin-conjugated clone ICRF44) from eBioscience (San Diego, CA, USA); CD235a (allophycocyanin-conjugated clone GA-R2) from BD (Franklin Lakes, NJ, USA); and CD33 (allophycocyanin-conjugated clone D3HL60.251) and CD45 (phycoerythrin-Cy7-conjugated clone J.33) from Beckman Coulter (Miami, FL, USA).
###end p 73
###begin title 74
###xml 31 36 <span type="species:ncbi:9606">human</span>
Microarray analysis of primary human CD34+ cells
###end title 74
###begin p 75
Sorted GFP-positive cells were snap-frozen 3 days after transduction and submitted to the Siteman Cancer Center Laboratory for Clinical Genomics where total RNA was isolated and target preparation and microarray hybridization were performed. Labeled targets were hybridized to Affymetrix HG-U133 Plus 2.0 GeneChip microarrays. Data were merged with the updated gene annotation data for each probe set on the array using Spotfire DecisionSite 9.1.1 for Functional Genomics (Spotfire, Somerville, MA). Probe sets were filtered according to present/absent calls and the sets that were absent across all chips were filtered from the analysis. The fold change of each probe set was calculated by dividing the absolute signal intensity from NUP98-HOXA9, NUP98-HOXA9/N51S, HOXA9, and HOXA9DeltaN samples by that of the control sample (vector only). Probes scored as increasing and absent in the numerator, and those scored as decreasing and absent in the denominator were also filtered out. The experiment was performed 2 independent times. Probe sets induced or repressed by 1.74-fold or greater in both experiments were considered differentially expressed. Gene intersection lists were generated using Spotfire DecisionSite 9.1.1 for Functional Genomics. All microarray data reported in the manuscript are described in accordance with MIAME guidelines.
###end p 75
###begin title 76
Luciferase assay
###end title 76
###begin p 77
###xml 182 185 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
Cells were transfected by electroporation using a Bio-Rad GenePulser with 10 microg pGL4.11 vector or pGL4.11 driven by the indicated promoters and 20 microg of either empty pTracer-CMV/Bsd vector, or vector expressing HA-tagged NUP98-HOXA9 or NUP98-HOXA9/N51S. To control for efficiency of transfection, 0.5 microg of pRL-TK (Promega), which expresses Renilla luciferase, was included. Ten million cells were incubated with the DNA for 10 min at room temperature (RT) before electroporation and 10 min after electroporation, and were cultured in 20 mL IMDM media with 10% FBS, 2 mM L-glutamine, and 100 units/mL pencillin/streptomycin. Luciferase activity was measured 48 h after electroporation using the Dual Luciferase Reporter Assay System (Promega) and the results were normalized to Renilla luciferase.
###end p 77
###begin title 78
Chromatin Immunoprecipitation
###end title 78
###begin p 79
###xml 8 9 8 9 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 422 423 422 423 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 589 590 585 586 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 601 602 597 598 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1719 1726 1663 1670 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KBTBD10</italic>
###xml 1728 1731 1672 1675 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLN</italic>
###xml 1737 1741 1681 1685 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HEY1</italic>
###xml 115 118 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
K562 (107) cells were nucleofected using a Nucleofector device (Lonza, Cologne, Germany) with either empty pTracer-CMV/Bsd vector or vector containing Flag-tagged NUP98-HOXA9 or NUP98-HOXA9/N51S and collected after 12 h. After crosslinking with 1% formaldehyde and quenching with 0.375 M glycine, cells were washed twice with ice-cold TBS. Nuclei were isolated by washing with 10 mM Tris-HCl, pH 7.5, 10 mM NaCl, 3 mM MgCl2, 0.5% NP-40 three times and were freeze-thawed. Nuclei were lysed by adding 200 microL of micrococcal nuclease buffer (10 mM Tris-HCl, pH 7.5, 200 mM NaCl, 3 mM MgCl2, 1 mM CaCl2, 4% NP-40, 3 mM EGTA, 1% SDS) and 1 mL FA lysis buffer (50 mM HEPES-NaOH, pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% sodium deoxycholate, 0.1% SDS) with 2 mM PMSF and complete protease inhibitor cocktail (Roche). The lysate was sonicated and centrifuged at 17,000xg for 30 min at 4degreesC. The supernatant was precleared with Sepharose 4B beads (GE Healthcare, Piscataway, NJ, USA) for 2 h at 4degreesC and incubated with anti-Flag agarose M2 antibody (Sigma) overnight at 4degreesC. The beads were washed twice with FA lysis buffer, once with of FA lysis buffer with 500 mM NaCl, once with ChIP wash buffer (10 mM Tris-HCl, pH 7.5, 0.25 M LiCl, 1 mM EDTA, 0.5% NP-40, 0.5% sodium deoxycholate), and once with TE (10 mM Tris-HCl pH 7.5, 1 mM EDTA). The beads were eluted twice at 65degreesC for 10 min with a total of 250 microL of 1% SDS in TE. After adding 250 microl TE and 100 microg proteinase K, the eluate was incubated at 37degreesC for 2 h. Crosslinks were reversed at 65degreesC overnight followed by phenol chloroform extraction and DNA precipitation with 100 microL 4M LiCl and 1 mL ethanol. KBTBD10, PLN, and HEY1 promoter regions were amplified by PCR (35 cycles) using the following primer pairs:
###end p 79
###begin p 80
KBTBD10:
###end p 80
###begin p 81
###xml 9 38 9 38 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;CACATCTCATATTCTTGACCTTTGC3&#8242;</named-content>
Forward: 5'CACATCTCATATTCTTGACCTTTGC3'
###end p 81
###begin p 82
###xml 9 39 9 39 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;CTGGAACTTTTAATCACTAGGGAAAC3&#8242;</named-content>
Reverse: 5'CTGGAACTTTTAATCACTAGGGAAAC3'
###end p 82
###begin p 83
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLN</italic>
PLN (1):
###end p 83
###begin p 84
###xml 9 37 9 37 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;CCATAAAGTTGCCCTTAATACTGC3&#8242;</named-content>
Forward: 5'CCATAAAGTTGCCCTTAATACTGC3'
###end p 84
###begin p 85
###xml 9 33 9 33 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;CTTGTGTGTATGGGAGAAGG3&#8242;</named-content>
Reverse: 5'CTTGTGTGTATGGGAGAAGG3'
###end p 85
###begin p 86
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLN</italic>
PLN (2):
###end p 86
###begin p 87
###xml 9 39 9 39 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;CCCGGCTTTACAAAAAAATTATTTCC3&#8242;</named-content>
Forward: 5'CCCGGCTTTACAAAAAAATTATTTCC3'
###end p 87
###begin p 88
###xml 9 35 9 35 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;CACCCCCAAAATAGCAATATGC3&#8242;</named-content>
Reverse: 5'CACCCCCAAAATAGCAATATGC3'
###end p 88
###begin p 89
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLN</italic>
PLN (3):
###end p 89
###begin p 90
###xml 8 41 8 41 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;CAAATGATTTGCTCTAGAGATGGATTTTC3&#8242;</named-content>
Forward:5'CAAATGATTTGCTCTAGAGATGGATTTTC3'
###end p 90
###begin p 91
###xml 9 30 9 30 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;CGGGCATCATTCTCCTC3&#8242;</named-content>
Reverse: 5'CGGGCATCATTCTCCTC3'
###end p 91
###begin p 92
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HEY1</italic>
HEY1:
###end p 92
###begin p 93
###xml 9 33 9 33 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;TCACGTGGCACCCAGTACAC3&#8242;</named-content>
Forward: 5'TCACGTGGCACCCAGTACAC3'
###end p 93
###begin p 94
###xml 9 33 9 33 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;GCATCTCATTTCCGGGGAAG3&#8242;</named-content>
Reverse: 5'GCATCTCATTTCCGGGGAAG3'
###end p 94
###begin p 95
PCR products were resolved on 2% agarose gels and imaged with a Chemidoc XRS system (Bio-Rad).
###end p 95
###begin title 96
Supporting Information
###end title 96
###begin p 97
###xml 137 140 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
Early NUP98-HOXA9 target genes in K562 cells identified by microarray analysis. K562 cells were nucleofected with either control pTracer-CMV/Bsd plasmid or with plasmid expressing NUP98-HOXA9 followed by sorting for GFP expression. Cells were harvested 8 h after nucleofection and RNA was subjected to microarray analysis using Affymetrix HG-U133 Plus 2.0 GeneChip microarrays. The experiment was performed 2 independent times and genes showing 2-fold or higher dysregulation compared to control in both experiments are listed in the table. The fold change shown is the average of the 2 experiments. In cases where more than one probe corresponds to the same gene, the number shown represents the average fold change shown by all the probes representing that gene in the two experiments. Dysregulation of several genes was confirmed by quantitative RT-PCR. Reverse transcription was performed with the SuperScript III kit (Invitrogen), according to the manufacturer's protocol. Quantitative RT-PCR was performed using the GeneAmp 5700 sequence Detection System using iQ SYBR Green Supermix (Bio Rad). The signal intensities were normalized against glyceraldehyde-3-phosphate dehydrogenase (GAPDH); the numbers shown represent fold change compared to control.
###end p 97
###begin p 98
(0.01 MB PDF)
###end p 98
###begin p 99
Click here for additional data file.
###end p 99
###begin p 100
###xml 43 48 <span type="species:ncbi:9606">human</span>
Genes dysregulated by NUP98-HOXA9. Primary human CD34+ cells were retrovirally transduced with either control MSCV-IRES-GFP vector or vector expressing NUP98-HOXA9. Cells were sorted for GFP positivity and total RNA was subjected to microarray analysis. The experiment was performed two independent times and only genes that showed up- or down-regulation by 1.74 fold or more compared to control in both experiments were considered dysregulated.
###end p 100
###begin p 101
(0.07 MB PDF)
###end p 101
###begin p 102
Click here for additional data file.
###end p 102
###begin p 103
###xml 48 53 <span type="species:ncbi:9606">human</span>
Genes dysregulated by NUP98-HOXA9/N51S. Primary human CD34+ cells were retrovirally transduced with either control MSCV-IRES-GFP vector or vector expressing NUP98-HOXA9/N51S. Cells were sorted for GFP positivity and total RNA was subjected to microarray analysis. The experiment was performed two independent times and only genes that showed up- or down-regulation by 1.74 fold or more compared to control in both experiments were considered dysregulated.
###end p 103
###begin p 104
(0.02 MB PDF)
###end p 104
###begin p 105
Click here for additional data file.
###end p 105
###begin p 106
###xml 47 52 <span type="species:ncbi:9606">human</span>
Genes dysregulated by wild-type HOXA9. Primary human CD34+ cells were retrovirally transduced with either control MSCV-IRES-GFP vector or vector expressing wild-type HOXA9. Cells were sorted for GFP positivity and total RNA was subjected to microarray analysis. The experiment was performed two independent times and only genes that showed up- or down-regulation by 1.74 fold or more compared to control in both experiments were considered dysregulated.
###end p 106
###begin p 107
(0.06 MB PDF)
###end p 107
###begin p 108
Click here for additional data file.
###end p 108
###begin p 109
###xml 43 48 <span type="species:ncbi:9606">human</span>
Genes dysregulated by HOXA9DeltaN. Primary human CD34+ cells were retrovirally transduced with either control MSCV-IRES-GFP vector or vector expressing HOXA9DeltaN. Cells were sorted for GFP positivity and total RNA was subjected to microarray analysis. The experiment was performed two independent times and only genes that showed up- or down-regulation by 1.74 fold or more compared to control in both experiments were considered dysregulated.
###end p 109
###begin p 110
(0.03 MB PDF)
###end p 110
###begin p 111
Click here for additional data file.
###end p 111
###begin p 112
###xml 177 182 <span type="species:ncbi:9606">human</span>
The FG repeat region of NUP98-HOXA9 has a partial effect on differentiation. The NUP98 portion of NUP98-HOXA9 (NUP98DeltaC) was subcloned into the MSCV-IRES-GFP vector. Primary human CD34+ cells were retrovirally transduced with either control MSCV-IRES-GFP vector or vector expressing NUP98DeltaC, and were sorted for GFP positivity. (A) Flow cytometry for myeloid differentiation: Cells from CFC plates were harvested and stained with CD45, CD33 and CD11b; the CD33+ gate was plotted on a histogram to show CD11b expression compared to control (lower panel). The data show a mild decrease in the number of myeloid cells with shift to immaturity in cells expressing NUP98DeltaC. (B) Flow cytometry for erythroid differentiation: Cells from CFC plates were harvested and stained with antibodies to CD45 and CD235a. The CD235a+ gate was plotted on a histogram (lower panel) to show the expression of CD235a relative to control cells. (C) Sorted cells were grown in liquid culture in the presence of cytokines and the cumulative fold increase in cell numbers compared to day 0 is plotted on a logarithmic scale against time.
###end p 112
###begin p 113
(0.88 MB TIF)
###end p 113
###begin p 114
Click here for additional data file.
###end p 114
###begin p 115
###xml 58 62 <span type="species:ncbi:162683">Mayo</span>
The HOXA9DeltaN cDNA was a gift from Dr. Jan van Deursen (Mayo Clinic). We thank the Alvin J. Siteman Cancer Center at Washington University School of Medicine and Barnes-Jewish Hospital in St. Louis, MO, for the use of the High Speed Cell Sorter Core, which provided flow cytometry analysis and sorting services and for the use of the Multiplexed Gene Analysis Core, which provided Affymetrix GeneChip microarray services.
###end p 115
###begin title 116
References
###end title 116
###begin article-title 117
The t(7;11)(p15;p15) translocation in acute myeloid leukaemia fuses the genes for nucleoporin NUP98 and class I homeoprotein HOXA9.
###end article-title 117
###begin article-title 118
###xml 98 103 <span type="species:ncbi:9606">human</span>
Fusion of the nucleoporin gene NUP98 to HOXA9 by the chromosome translocation t(7;11)(p15;p15) in human myeloid leukaemia.
###end article-title 118
###begin article-title 119
Hox genes in hematopoiesis and leukemogenesis.
###end article-title 119
###begin article-title 120
CREB binding protein interacts with nucleoporin-specific FG repeats that activate transcription and mediate NUP98-HOXA9 oncogenicity.
###end article-title 120
###begin article-title 121
###xml 40 45 <span type="species:ncbi:9606">human</span>
NUP98 is fused to PMX1 homeobox gene in human acute myelogenous leukemia with chromosome translocation t(1;11)(q23;p15).
###end article-title 121
###begin article-title 122
The oncogene Nup98-HOXA9 induces gene transcription in myeloid cells.
###end article-title 122
###begin article-title 123
HOXA9 activates transcription of the gene encoding gp91Phox during myeloid differentiation.
###end article-title 123
###begin article-title 124
Trans-repressive effect of NUP98-PMX1 on PMX1-regulated c-FOS gene through recruitment of histone deacetylase 1 by FG repeats.
###end article-title 124
###begin article-title 125
NUP98-NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis.
###end article-title 125
###begin article-title 126
Leukemogenic properties of NUP98-PMX1 are linked to NUP98 and homeodomain sequence functions but not to binding properties of PMX1 to serum response factor.
###end article-title 126
###begin article-title 127
###xml 39 43 <span type="species:ncbi:10090">mice</span>
###xml 51 56 <span type="species:ncbi:9606">human</span>
Induction of acute myeloid leukemia in mice by the human leukemia-specific fusion gene NUP98-HOXD13 in concert with Meis1.
###end article-title 127
###begin article-title 128
###xml 96 100 <span type="species:ncbi:10090">mice</span>
NUP98-HOXA9 expression in hemopoietic stem cells induces chronic and acute myeloid leukemias in mice.
###end article-title 128
###begin article-title 129
Nup98-HoxA9 immortalizes myeloid progenitors, enforces expression of Hoxa9, Hoxa7 and Meis1, and alters cytokine-specific responses in a manner similar to that induced by retroviral co-expression of Hoxa9 and Meis1.
###end article-title 129
###begin article-title 130
NUP98-topoisomerase I acute myeloid leukemia-associated fusion gene has potent leukemogenic activities independent of an engineered catalytic site mutation.
###end article-title 130
###begin article-title 131
###xml 82 87 <span type="species:ncbi:9606">human</span>
NUP98-HOXA9 induces long-term proliferation and blocks differentiation of primary human CD34+ hematopoietic cells.
###end article-title 131
###begin article-title 132
###xml 38 43 <span type="species:ncbi:9606">human</span>
Enforced expression of NUP98-HOXA9 in human CD34(+) cells enhances stem cell proliferation.
###end article-title 132
###begin article-title 133
Hoxa9 immortalizes a granulocyte-macrophage colony-stimulating factor- dependent promyelocyte capable of biphenotypic differentiation to neutrophils or macrophages, independent of enforced meis expression.
###end article-title 133
###begin article-title 134
NUP98 rearrangements in hematopoietic malignancies: a study of the Groupe Francophone de Cytogenetique Hematologique.
###end article-title 134
###begin article-title 135
Candidate genes for expansion and transformation of hematopoietic stem cells by NUP98-HOX fusion genes.
###end article-title 135
###begin article-title 136
Leukemogenic mechanisms and targets of a NUP98/HHEX fusion in acute myeloid leukemia.
###end article-title 136
###begin article-title 137
Homeodomain proteins.
###end article-title 137
###begin article-title 138
Homeodomain-DNA recognition.
###end article-title 138
###begin article-title 139
PBX and MEIS as non-DNA-binding partners in trimeric complexes with HOX proteins.
###end article-title 139
###begin article-title 140
###xml 42 47 <span type="species:ncbi:9606">human</span>
Functional characterization of individual human hematopoietic stem cells cultured at limiting dilution on supportive marrow stromal layers.
###end article-title 140
###begin article-title 141
###xml 28 33 <span type="species:ncbi:9606">human</span>
###xml 38 43 <span type="species:ncbi:10090">mouse</span>
Comparative analysis of the human and mouse Hey1 promoter: Hey genes are new Notch target genes.
###end article-title 141
###begin article-title 142
Integration of TGF-beta/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition.
###end article-title 142
###begin article-title 143
A ras-related gene with transformation suppressor activity.
###end article-title 143
###begin article-title 144
Does Rap1 deserve a bad Rap?
###end article-title 144
###begin article-title 145
Multiple roles of Rap1 in hematopoietic cells: complementary versus antagonistic functions.
###end article-title 145
###begin article-title 146
###xml 108 113 <span type="species:ncbi:9606">human</span>
Induction of smg p21/rap1A p21/krev-1 p21 gene expression during phorbol ester-induced differentiation of a human megakaryocytic leukemia cell line.
###end article-title 146
###begin article-title 147
Thrombopoietin-mediated sustained activation of extracellular signal-regulated kinase in UT7-Mpl cells requires both Ras-Raf-1- and Rap1-B-Raf-dependent pathways.
###end article-title 147
###begin article-title 148
###xml 94 99 <span type="species:ncbi:9606">human</span>
Expression, activation, and subcellular localization of the Rap1 GTPase in cord blood-derived human megakaryocytes.
###end article-title 148
###begin article-title 149
Stromal inhibition of megakaryocytic differentiation is associated with blockade of sustained Rap1 activation.
###end article-title 149
###begin article-title 150
Rap1 is activated by erythropoietin or interleukin-3 and is involved in regulation of beta1 integrin-mediated hematopoietic cell adhesion.
###end article-title 150
###begin article-title 151
Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics.
###end article-title 151
###begin article-title 152
Cyclooxygenase-2 (cox-2) and the inflammogenesis of cancer.
###end article-title 152
###begin article-title 153
Targeting cyclooxygenase-2 in hematological malignancies: rationale and promise.
###end article-title 153
###begin article-title 154
The role of non-steroidal anti-inflammatory drugs in the risk of development and treatment of hematologic malignancies.
###end article-title 154
###begin article-title 155
Prescription drug use and risk of acute myeloid leukemia by French-American-British subtype: results from a Los Angeles County case-control study.
###end article-title 155
###begin article-title 156
HES and HERP families: multiple effectors of the Notch signaling pathway.
###end article-title 156
###begin article-title 157
Gene expression profiling provides insights into the pathways involved in solid pseudopapillary neoplasm of the pancreas.
###end article-title 157
###begin article-title 158
###xml 51 56 <span type="species:ncbi:9606">Human</span>
Notch Signaling Contributes to the Pathogenesis of Human Osteosarcomas.
###end article-title 158
###begin article-title 159
A role for the transcription factor HEY1 in glioblastoma.
###end article-title 159
###begin article-title 160
Induction of CCL2 by siMAML1 through upregulation of TweakR in melanoma cells.
###end article-title 160
###begin article-title 161
###xml 82 87 <span type="species:ncbi:9606">human</span>
Gamma-secretase inhibitor prevents Notch3 activation and reduces proliferation in human lung cancers.
###end article-title 161
###begin article-title 162
HNF4alpha reduces proliferation of kidney cells and affects genes deregulated in renal cell carcinoma.
###end article-title 162
###begin article-title 163
Converging pathways in leukemogenesis and stem cell self-renewal.
###end article-title 163
###begin article-title 164
Mechanisms and clinical prospects of Notch inhibitors in the therapy of hematological malignancies.
###end article-title 164
###begin article-title 165
mNotch1 signaling and erythropoietin cooperate in erythroid differentiation of multipotent progenitor cells and upregulate beta-globin.
###end article-title 165
###begin article-title 166
Jun blockade of erythropoiesis: role for repression of GATA-1 by HERP2.
###end article-title 166
###begin article-title 167
Disorder in the nuclear pore complex: the FG repeat regions of nucleoporins are natively unfolded.
###end article-title 167
###begin article-title 168
Rapid evolution exposes the boundaries of domain structure and function in natively unfolded FG nucleoporins.
###end article-title 168
###begin article-title 169
The Abd-B-like Hox homeodomain proteins can be subdivided by the ability to form complexes with Pbx1a on a novel DNA target.
###end article-title 169
###begin article-title 170
The nucleoporin nup98 is a site for GDP/GTP exchange on ran and termination of karyopherin beta 2-mediated nuclear import.
###end article-title 170
###begin article-title 171
Identification of a protein complex that is required for nuclear protein import and mediates docking of import substrate to distinct nucleoporins.
###end article-title 171
###begin article-title 172
###xml 32 37 <span type="species:ncbi:9606">human</span>
Cloning and characterization of human karyopherin beta3.
###end article-title 172
###begin article-title 173
RAE1 is a shuttling mRNA export factor that binds to a GLEBS-like NUP98 motif at the nuclear pore complex through multiple domains.
###end article-title 173
###begin article-title 174
Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia.
###end article-title 174
###begin article-title 175
Quantitative HOX expression in chromosomally defined subsets of acute myelogenous leukemia.
###end article-title 175
###begin article-title 176
###xml 129 134 <span type="species:ncbi:9606">human</span>
Expression of HOX genes, HOX cofactors, and MLL in phenotypically and functionally defined subpopulations of leukemic and normal human hematopoietic cells.
###end article-title 176
###begin article-title 177
###xml 64 69 <span type="species:ncbi:9606">human</span>
Frequent co-expression of the HOXA9 and MEIS1 homeobox genes in human myeloid leukemias.
###end article-title 177
###begin p 178
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 178
###begin p 179
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by National Institutes of Health grants R01 HL082549 and K02 HL084179 (N.R.Y.), and by T32 CA009547 (A.M.A.). The Siteman Cancer Center is supported in part by an NCI Cancer Center Support Grant #P30 CA91842. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 179

